Vaccines - Iraq

Iraq

In Iraq, the Vaccines market is anticipated to witness a substantial increase in revenue, reaching US$84.99m by the year 2024.
This growth is expected to continue with an annual growth rate of 4.34% from 2024 to 2029, resulting in a market volume of US$105.10m by the end of 2029.
It is interesting to note that in the global context, United States is projected to generate the highest revenue, amounting to US$29,120.00m in 2024.
The demand for vaccines in Iraq has significantly increased due to the ongoing efforts to combat various infectious diseases.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Iraq has been increasing steadily in recent years.

Customer preferences: Iraq's population has become increasingly aware of the importance of vaccinations in maintaining good health. As a result, there has been a growing demand for vaccines among both children and adults. The government has also been actively promoting vaccination programs, which has contributed to the rise in demand.

Trends in the market: The vaccines market in Iraq has been growing steadily over the past few years. This growth can be attributed to several factors, including an increase in the number of vaccination programs, a rise in the number of private clinics and hospitals, and an increase in public awareness about the importance of vaccinations.

Local special circumstances: Iraq has faced numerous challenges in recent years, including political instability, economic uncertainty, and ongoing conflicts. Despite these challenges, the demand for vaccines has remained strong, as people recognize the importance of protecting themselves and their families from preventable diseases.

Underlying macroeconomic factors: The Iraqi government has been investing heavily in healthcare infrastructure in recent years, which has helped to support the growth of the vaccines market. Additionally, the country's young and growing population has created a large market for vaccines, as parents seek to protect their children from a range of illnesses. Overall, the outlook for the vaccines market in Iraq is positive, with continued growth expected in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.